ECMELLA as a bridge to heart transplantation in refractory ventricular fibrillation: A case report.

Détails

Ressource 1Télécharger: fcvm-10-1074544.pdf (1850.23 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_6E4FADC87E6B
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
ECMELLA as a bridge to heart transplantation in refractory ventricular fibrillation: A case report.
Périodique
Frontiers in cardiovascular medicine
Auteur⸱e⸱s
Giraud R., Assouline B., Burri H., Shah D., Meyer P., Degrauwe S., Kirsch M., Bendjelid K.
ISSN
2297-055X (Print)
ISSN-L
2297-055X
Statut éditorial
Publié
Date de publication
02/2023
Peer-reviewed
Oui
Volume
10
Pages
1074544
Langue
anglais
Notes
Publication types: Case Reports
Publication Status: epublish
Résumé
Extracorporeal membrane oxygenation (ECMO) is an effective cardiorespiratory support technique in refractory cardiac arrest (CA). In patients under veno-arterial ECMO, the use of an Impella device, a microaxial pump inserted percutaneously, is a valuable strategy through a left ventricular unloading approach. ECMELLA, a combination of ECMO with Impella, seems to be a promising method to support end-organ perfusion while unloading the left ventricle.
The present case report describes the clinical course of a patient with ischemic and dilated cardiomyopathy who presented with refractory ventricular fibrillation (VF) leading to CA in the late postmyocardial infarction (MI) period, and who was successfully treated with ECMO and IMPELLA as a bridge to heart transplantation.
In the case of CA on VF refractory to conventional resuscitation maneuvers, early extracorporeal cardiopulmonary resuscitation (ECPR) associated with an Impella seems to be the best strategy. It provides organ perfusion, left ventricular unloading, and ability for neurological evaluation and VF catheter ablation before allowing heart transplantation. It is the treatment of choice in cases of end-stage ischaemic cardiomyopathy and recurrent malignant arrhythmias.
Mots-clé
ECMELLA, Impella, VA-ECMO, cardiac arrest, heart transplantation, refractory ventricular fibrillation
Pubmed
Web of science
Open Access
Oui
Création de la notice
03/03/2023 13:43
Dernière modification de la notice
17/10/2023 7:19
Données d'usage